LuSIV Cells: A Reporter Cell Line for the Detection and Quantitation of a Single Cycle of HIV and SIV Replication  by Roos, Jason W. et al.
d
(
Virology 273, 307–315 (2000)
doi:10.1006/viro.2000.0431, available online at http://www.idealibrary.com onLuSIV Cells: A Reporter Cell Line for the Detection and Quantitation
of a Single Cycle of HIV and SIV Replication
Jason W. Roos,* Maureen F. Maughan,† Zhaohao Liao,‡ James E. K. Hildreth,‡ and Janice E. Clements*,1
*Department of Comparative Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; †AlphaVax Human Vaccines,
710 West Main Street, Durham, North Carolina 27701; and ‡The Leukocyte Immunochemistry Laboratory, Department
of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, Maryland 21205
Received October 21, 1999; returned to author for revision December 13, 1999; accepted May 12, 2000
A single cycle of viral replication is the time required for a virus to enter the host cell, replicate its genome, and produce
infectious progeny virions. The primate lentiviruses, human immunodeficiency virus (HIV) and simian immunodeficiency virus
(SIV), require on average 24 h to complete one cycle of replication. We have now developed and characterized a reporter
assay system in CEMx174 cells for the quantitative measurement of HIV/SIV infection within a single replication cycle. The
SIVmac239 LTR (2225 3 1149) was cloned upstream of the firefly luciferase reporter gene and this reporter plasmid is
maintained in CEMx174 cells under stable selection. This cell line, designated LuSIV, is highly sensitive to infection by primary
and laboratory strains of HIV/SIV, resulting in Tat-mediated expression of luciferase, which correlates with viral infectivity.
Furthermore, manipulation of LuSIV cells for the detection of luciferase activity is easy to perform and requires a minimal
amount of time as compared to current HIV/SIV detection systems. The LuSIV system is a powerful tool for the analysis of
HIV/SIV infection that provides a unique assay system that can detect virus replication prior to 24 h and does not require
virus to spread from cell to cell. Thus these cells can be used for the study of replication-deficient viruses and the high
throughput screening of antivirals, or other inhibitors of infection. © 2000 Academic PressINTRODUCTION
The human immunodeficiency virus (HIV) and simian
immunodeficiency virus (SIV) are members of the lenti-
virus family and are the causative agents for the acquired
immunodeficiency syndrome (AIDS) in primates. Since
the mechanisms of viral infection in primates are com-
plicated by the interplay of the host immune responses,
the study of lentivirus infection in tissue culture has
proved to be a useful model for the analysis of viral
replication and pathogenesis in vivo. The retroviral life
cycle can be separated into two parts: the early events
required for entry and establishment of productive infec-
tion and the late events responsible for assembly, per-
sistence, and spread of infection (Varmus, 1982).
To study the mechanisms of the retroviral life cycle, it
is crucial for a viral replication assay to detect a single
round of infection, which is the time required for a virus
to infect the host cell and produce the first round of
progeny virions. For HIV/SIV a single replication cycle is
approximately 24 h and is dependent on the number and
the intrinsic infectivity of infectious particles used as the
viral input (Varmus, 1982). To study the mechanisms of
viral persistence and spread, an assay that can follow
1 To whom correspondence and reprint requests should be ad-
ressed at 720 Rutland Avenue, Traylor G-60, Baltimore, MD 21205. Fax:
410) 955-9823. E-mail: jclement@jhmi.edu.
307HIV/SIV infection over time is required. An ideal assay
system would provide the ability to detect early and late
events in a single round of infection as well as have the
capability to measure infection over time. In addition, this
system would be sensitive to infection by phenotypically
diverse virus isolates.
Of the current techniques available for measuring viral
infection, systems that measure the total number of viral
particles such as reverse transcriptase assays or ELISA-
based assays to detect viral antigen are useful for fol-
lowing infection over time. However, they are limited by
the requirement for the production of threshold levels of
viral particles as a readout, are unable to detect a single
round of infection, or are unable to discriminate between
infectious and noninfectious particles. Assays such as
endpoint dilution that utilize syncytia formation or cyto-
pathic effects (CPE) as readouts are useful for determin-
ing the number of infectious particles, yet are time con-
suming because of the requirement for viral spread and
formation of syncytia. In addition, these techniques are
biased against viral strains that do not cause fusion and
syncytia formation during persistent infection and are
also unable to detect a single round of infection.
Many of the cell-based assay systems designed to
study HIV/SIV infection utilize the viral LTR activated by
the viral transactivating protein Tat early in infection to
drive expression of a reporter gene. These LTR-based
assay systems employ the LTR fused to GFP (Gervaix et
0042-6822/00 $35.00
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308 ROOS ET AL.al., 1997), b-galactosidase (Chackerian et al., 1995; Kimp-
on and Emerman, 1992), CAT (Felber and Pavlakis,
988), secreted alkaline phosphatase (SEAP) (Berger et
l., 1988), or luciferase (Aguilar-Cordova et al., 1994). Of
he cell-based HIV/SIV infection assay systems that em-
loy these reporter constructs few have been successful
n achieving a high level of sensitivity. To date, the most
ommonly used assays are the multinuclear activation of
alactosidase indicator (MAGI/sMAGI) systems (Chack-
rian et al., 1995; Kimpton and Emerman, 1992). The
AGI/sMAGI assays utilize the viral LTR from HIV and
IV, respectively, to drive expression of the b-galactosi-
dase reporter gene. Although these cell systems may be
capable of detecting a single round of HIV/SIV infection,
b-gal activity is measured 2–3 days postinfection and
may be affected by virus spread.
We have developed an LTR-based assay system in
CEMx174 cells (Salter et al., 1985) that is sensitive
nough to detect a single round of HIV/SIV infection
ithin 24 h of exposing cells to virus. Using a truncated
ortion of the SIVmac239 LTR cloned upstream of the
firefly luciferase reporter gene we generated a stable cell
line containing this episomally maintained reporter plas-
mid. This cell line, named LuSIV, is sensitive to induction
of luciferase expression by HIV and SIV Tat, and lucif-
erase activity directly correlates with viral infectivity.
The LuSIV cells provide the advantage of detecting a
single round of infection, while requiring only picogram
quantities of p24/p27 as viral input, and the infectivity of
primary and laboratory strains of HIV/SIV can be de-
tected using these cells. The measurement of luciferase
activity requires minimal amounts of time, is easily per-
formed, and can be used for high throughput assays. The
LuSIV system is an effective tool to study the general
biology of HIV/SIV infection and can be extended to the
study of replication-defective viruses used in vaccine
development and the screening of inhibitors of viral in-
fection.
RESULTS
Construction of reporter plasmid that is
transactivated by SIV and HIV Tat
We have engineered a pLuc reporter construct con-
taining the SIVmac239 LTR cloned upstream of the firefly
uciferase reporter gene. Activation of pLuc requires the
IV/SIV viral transactivating protein Tat to drive expres-
ion of the luciferase reporter gene from the LTR. The
runcated portion of the SIV LTR (22253 1149) used to
construct pLuc was previously shown to be the minimal
region required for efficient transactivation of the SIV
genome (Anderson and Clements, 1992). This region of
the SIV LTR minimizes background activation from cel-
lular transcription factors while maintaining optimal sen-
sitivity to Tat. The HIV and SIV Tat proteins depend on the
same consensus NFkB and SP1 sites within the LTRFranza et al., 1987; Garcia et al., 1987; Jones et al., 1986;
abel and Baltimore, 1987) and have been shown to be
nterchangeable with respect to their ability to transacti-
ate either the SIV or HIV genome (Viglianti and Mullins,
988). The portion of the LTR in pLuc contains the NFkB
and SP1 consensus sites and we anticipated that both
SIV and HIV Tat would induce luciferase expression.
To test the reporter construct and confirm its sensitivity
to HIV/SIV Tat, we cotransfected CEMx174 cells with
equal amounts of pLuc and DNA encoding SIV tat, HIV
tat, or visna virus tat as a negative control. Visna virus Tat
does not activate transcription through the NFkB and
P1 sites that are within the HIV/SIV LTR but, instead,
ses AP1 and AP4 consensus binding sites (Gabuzda et
l., 1989; Gdovin and Clements, 1992; Hess et al., 1989;
altarelli et al., 1990). For this reason, we predicted that
isna virus Tat would not transactivate the SIVmac239 LTR.
t 24 h posttransfection 2.0 3 105 cells from each trans-
fection were analyzed for luciferase activity. The cells
transfected with both the pLuc and SIV or HIV Tat con-
structs showed a .300-fold increase in luciferase activ-
ity as compared to those cells transfected with pLuc
alone (Fig. 1A). In contrast, visna virus Tat did not induce
luciferase activity. Whereas HIV and SIV Tat showed the
highest level of induction at 24 h posttransfection, a
30-fold increase in activity could be detected as early as
5 h posttransfection (data not shown), indicating that Tat
is a very efficient inducer of luciferase activity.
To ascertain whether this Tat-mediated induction of
luciferase could also occur in the context of the entire
viral genome, we next cotransfected CEMx174 cells with
equal amounts of pLuc and infectious HIVNL4–3 or
IVmac239 DNA. At 48 h posttransfection a .700-fold
ncrease in luciferase activity was observed for SIVmac239
nd a .450-fold induction with HIVNL4–3 (Fig. 1B).
eneration of LuSIV cells
To develop a stable cell line containing the pLuc con-
truct, we chose CEMx174 cells, which are susceptible to
nfection by T-cell-tropic strains of HIV and by molecular
lones and primary strains of SIV (Emau et al., 1991; Sei
t al., 1990; Stefano et al., 1993). The pLuc plasmid was
onstructed in the background of the pCEP4 plasmid,
hich carries the hygromycin B resistance gene for use
n selecting stable cells and is maintained episomally
hrough EBNA-1 (Sugden et al., 1985; Yates et al., 1985).
e transfected CEMx174 cells with 12 mg of pLuc and
elected a stable cell population with hygromycin B. The
ells were cloned by limiting dilution under selection
ith hygromycin B (300 mg/ml) and screened for their
ability to induce luciferase activity upon infection with
SIV (data not shown). The final cloned cells that yielded
the highest signal-to-noise ratio, pLuc6.3a, were used for
all further experiments and are hereafter referred to as
the LuSIV cells.
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309LuSIV CELLSOptimization and infection of LuSIV cells
Once a stable cell line was isolated, it was necessary
to optimize the conditions of infection to give the best
induction of luciferase activity. To lower the background
in the LuSIV cells, we reduced the FBS concentration in
the tissue culture medium from 10 to 2%. Although this
change did have a modest effect on the background
luciferase activity, we suspected that something in the
viral inoculum was inhibiting the infection process, since
increasing amounts of viral input did not result in an
increase in luciferase activity.
To test this hypothesis, we pelleted varying amounts of
SIV/17E-Fr (calculated on the basis of RT activity) and
resuspended the virus for inoculation in conditioned me-
dium (the supernatant from which it was pelleted), se-
rum-free cRPMI or cRPMI with 2% FBS. Using these virus
preparations, we infected LuSIV cells (2.0 3 105 cells/
well) in 96-well flat-bottom dishes, and assayed them for
luciferase activity at 24 h postinfection. The maximum
luciferase induction of the inoculum containing the con-
FIG. 1. Luciferase activity from the pLuc reporter plasmid. CEMx174
ells were cotransfected with pLuc and HIV, SIV, visna virus tat (A), or
with HIV or SIV viral genomes (B). For each time point the luciferase
assay was performed as described under Materials and Methods
using 2.0 3 105 viable cells. Values are shown as fold induction of
uciferase activity over background activity, and the data are represen-
ative of three independent experiments.ditioned medium was 4.5-fold; however, this induction
was not as robust as that observed for the serum-free(18-fold) or 2% cRPMI (42-fold) samples, nor was the
induction titratable with increasing amounts of virus in-
put (Fig. 2). As a consequence, in all subsequent exper-
iments involving infection with SIV the virus was pelleted
as described under Materials and Methods and resus-
pended in fresh RPMI with 2% FBS.
Detection of a single round of HIV and SIV infection
To examine the capability of LuSIV cells to detect a
single replication cycle, we infected the LuSIV cells
(1.5 3 105) with SIV/17E-Fr for 6 h, washed off the virus
noculum, and treated the cells with the RT inhibitor AZT
10 mM) for the remainder of the infection. Infection with
SIV/17E-Fr resulted in significant luciferase induction in
both untreated and AZT-treated samples (Fig. 3). Since
AZT inhibits RT activity, the luciferase activity detected
24 h postinfection reflects the infectivity of those virions
that entered and initiated reverse transcription prior to
AZT treatment. The difference in luciferase induction
observed between the untreated and AZT-treated sam-
ples is likely the result of the activity of virions that either
just entered the cells or were in the process of fusion at
the time the virus inoculum was removed (Fig. 3). How-
ever, in the AZT-treated samples, virions in this state
would be inhibited by the drug and result in an overall
lower-fold induction of luciferase activity as compared to
the untreated samples. Furthermore, to confirm the in-
hibitory effect of AZT one of the samples was treated
with AZT at the time of infection and did not demonstrate
a significant induction of luciferase activity (Fig. 3). The
ability to detect a significant induction of luciferase 24 h
postinfection in AZT-treated samples provides strong ev-
idence that the LuSIV cells do measure a single cycle of
SIV/HIV infection.
To evaluate single-cycle HIV/SIV infection with a panel
of virus strains, LuSIV cells were infected with a variety
FIG. 2. SIV infection of LuSIV cells. LuSIV cells were infected with
SIV/17E-Fr that was pelleted and resuspended in conditioned medium
(the supernatant from which it was pelleted), serum-free cRPMI, or
cRPMI with 2% FBS. Viral input was normalized by increasing quantities
of reverse transcriptase (RT) activity. The LuSIV cells were assayed for
luciferase activity 24 h postinfection, and values are represented as
fold induction of luciferase activity (6 SD) over background activity.
Data are mean values from duplicate infections.
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310 ROOS ET AL.of HIV/SIV stocks and measured for luciferase activity at
24 h postinfection. The standard input for each infection
was 25 ng of HIV (p24) or SIV (p27) viral core antigen.
Whereas the extent of the induction varied for each
strain, there was a significant induction associated with
each virus after a single round of infection (Table 1). In
other studies we have detected a robust luciferase ac-
tivity in as few as 16 h after exposing LuSIV cells to HIV
(data not shown). Furthermore, when the infection pro-
ceeded for 48 h the fold induction for each virus in-
creased significantly, demonstrating the ability of the
LuSIV cells to detect virus spread. The variability in the
FIG. 3. Detection of single-cycle SIV replication in LuSIV cells. LuSIV
cells were infected with 25 ng of SIV/17E-Fr for 6 h, washed, and either
treated with AZT (10 mM) to prevent viral spread or left untreated. To
ontrol for the inhibitory effect of AZT, one sample was treated with AZT
t the time of infection. The LuSIV cells were assayed for luciferase
ctivity 24 h postinfection, and values are represented as fold induction
f luciferase activity (6 SD) over background activity. Data are repre-
entative of three independent experiments and values are the means
rom quadruplicate infections.
TABLE 1
Luciferase Activity in LuSIV Cells at 24 and 48 h Postinfection
with Various Strains of HIV and SIV
Strain
Luciferase activity postinfection
(fold induction)
24 h 48 h
HIV
IIIb 38.6 6 8.76 2880 6 572
RF 187 6 10.9 4190 6 78.8
MN 44.4 6 1.15 426 6 4.77
SIV
17E-Br 161 6 21.8 1660 6 142
17E-Fr 115 6 14.8 1390 6 337
mac239 8.65 6 2.21 191 6 47.9
mac251 21.3 6 1.35 161 6 11.4
Delta B670 3.02 6 0.48 41.3 6 15.8
Note. Virus input was 25 ng of SIV p27 or HIV p24 viral core antigen.
uciferase activity is represented as the fold induction of luciferase
ctivity over background.extent of the induction between strains is an indication of
the difference in relative infectivity between the viruses
studied. These data indicated that LuSIV cells are highly
susceptible to HIV/SIV infection and are capable of de-
tecting a relatively small amount of virus input within a
single replication cycle.
Increase in luciferase induction in LuSIV cells over
time
In addition to their capacity for detecting a single
round of infection, the LuSIV cells are also useful for
detecting virus spread. If the standard virus input used to
infect the LuSIV cells is low (,1 multiplicity of infection),
not all of the LuSIV cells will be infected in the first round;
therefore, there will be additional susceptible cells for
subsequent infection. In addition to virus spread, lucif-
erase will accumulate over time in those cells that have
an established infection. To confirm that the luciferase
induction increases over time as infection proceeds, we
infected 2.0 3 105 LuSIV cells in triplicate with 25 ng of
IV/17E-Fr (p27) or HIVRF (p24). The cells were assayed
or luciferase activity at 24, 48, and 72 h postinfection
Fig. 4). HIVRF causes a robust infection that rapidly in-
creases by 48 h postinfection (.4000-fold induction), but
starts to diminish in 72 h. The decrease in luciferase
activity at 72 h is most likely the result of a decrease in
the viability of the LuSIV cells as they succumb to the
cytopathic effects of virus infection. SIV/17E-Fr induction
increased exponentially over the time period studied
(exceeding a 3000-fold induction). It is likely that this
trend would continue until the infection reached a pla-
teau and the cells begin to die as observed with HIVRF.
The ability of the LuSIV cells to reflect the growth kinetics
of a particular HIV/SIV virus strain makes this assay a
FIG. 4. Infection of LuSIV cells with SIV and HIV. LuSIV cells (2.0 3
105) were infected with 25 ng of SIV/17E-Fr p27 and HIVRF p24. At 24, 48,
and 72 h postinfection the LuSIV cells were assayed for luciferase
activity. The values are represented as fold induction of luciferase
activity (6 SD) over background activity and are the mean values of
infections performed in triplicate.useful tool for following HIV/SIV infection in vitro and
monitoring inhibitors of viral replication.
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311LuSIV CELLSSensitivity of LuSIV cells to HIV/SIV infection
We were interested in determining the lower limit of
virus input that would yield a significant increase in the
induction of luciferase activity over background in the
LuSIV cells. Starting with 25 ng of p27/p24, we made
fivefold serial dilutions of SIV/17E-Fr or HIVRF and in-
ected 2.0 3 105 LuSIV cells in triplicate. The cells were
analyzed for luciferase activity at 24 and 48 h postinfec-
tion (Table 2). A fourfold increase in luciferase activity
over background was considered the lower limit of sen-
sitivity for virus input. In a single round of replication (24
h), the assay was remarkably sensitive: as shown in
Table 2, the LuSIV cells could be used to detect infection
with 200 pg of HIVRF p24 and 1 ng of SIV/17E-Fr p27 input,
nd, after allowing the infection to proceed for 48 h, the
uSIV cells were able to detect 40 pg of HIVRF p24 and 40
g of SIV/17E-Fr p27.
To further demonstrate the sensitivity and usefulness
f the LuSIV assay we directly compared SIV infection in
uSIV and sMAGI cells by performing parallel infections
ith SIV/17E-Fr. The LuSIV cells were infected as de-
cribed under Materials and Methods and the sMAGI
ells were infected as previously described (Chackerian
t al., 1995). For each infection the virus inoculum (25 ng
f SIVp27) remained on the cells for the duration of the
nfection, and the cells were analyzed for luciferase or
b-gal activity 24 h postinfection. Consistently, the LuSIV
cells were at least three times more sensitive than the
sMAGI and as high as eight times more sensitive in
some instances (Fig. 5). In addition to the greater sensi-
tivity, the LuSIV assay required a third of the time that the
sMAGI assay required to set up for infection and process
for b-Gal activity.
DISCUSSION
TABLE 2
Sensitivity of LuSIV Cells to HIV and SIV Infection
at 24 and 48 h Postinfection
p24/p27
(pg)
Luciferase activity postinfection (fold induction)
HIVRF SIV/17E-Fr
24 h 48 h 24 h 48 h
40 3.78 6 1.09 81.2* 6 17.2 0 7.02* 6 2.17
200 5.24* 6 1.20 472 6 26.9 2.03 6 0.66 31.9 6 0.77
.0 3 103 10.2 6 1.39 1560 6 172 11.0* 6 0.62 160 6 14.0
.0 3 103 27.4 6 1.91 1630 6 264 60.2 6 2.96 790 6 26.2
.5 3 104 166 6 10.7 3890 6 350 225 6 11.1 4100 6 129
Note. The values designated by * represent the input sensitivity for
he LuSIV cells.We have developed a very sensitive and quantitative
TR-based infectivity assay system in CEMx174 cells that
oan detect infection by a broad range of HIV/SIV viral
trains. The LuSIV cells described in this study are ca-
able of detecting a single round of HIV/SIV infection.
he extent of viral infection in the LuSIV cells directly
eflects the viral input when used to measure a single
eplication cycle. Since virus does not spread in this time
rame, the luciferase signal is indicative of the virus that
as able to enter the cells and produce the Tat protein.
Several elements in the design of the LuSIV system
ave contributed to its high sensitivity to viral input, low
ackground luciferase activity, and high signal-to-noise
atio. The pLuc plasmid derived from the pCEP4 plasmid
s episomally maintained and, unlike plasmids that inte-
rate into genomic DNA, is unlikely to be influenced by
ndogenous promoters that may alter the expression of
uciferase in the absence of Tat. The portion of the
IVmac239 LTR (222531149) used to generate the pLuc
lasmid has been previously shown to be the minimal
egion required for efficient transactivation by SIV Tat
Anderson and Clements, 1992). The choice of luciferase
s a reporter contributed to the sensitivity of the assay,
s it can be detected at concentrations in the picomolar
ange (Wood, 1991). Finally, cloning of the LuSIV cells by
imiting dilution after stable selection allowed us to se-
ect a single clone representing the highest signal-to-
oise ratio of luciferase in response to infection.
One potential limitation of this assay system is that
EMx174 cells are in the lymphocyte lineage and sup-
ort infection by primary/molecular strains of SIV and
-cell-tropic (T-tropic) strains of HIV, but are unable to be
nfected with most macrophage-tropic (M-tropic) strains
f HIV-1 (Chen et al., 1997; Jolly, 1997; Stefano et al.,
993). The inability of CEMx174 cells to support infection
y M-tropic strains of HIV-1 results from the lack of
xpression of the necessary chemokine coreceptors,
FIG. 5. SIV infection in LuSIV and sMAGI cells. The sensitivities of
LuSIV and sMAGI cells were directly compared by parallel infection
with 25 ng of SIV/17E-Fr. Each assay system was prepared for infection
as described under Materials and Methods. At 24 h postinfection the
LuSIV and sMAGI cells were analyzed for luciferase and b-Gal activity,
espectively. The values are represented as fold induction of luciferase
r b-Gal activity (6 SD) over background activity and are the mean
values of infections performed in quadruplicate.
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312 ROOS ET AL.that is, CCR5 (Chen et al., 1997). Although this may be a
hortcoming of the LuSIV cells, we are in the process of
eveloping the assay system in a cell line susceptible to
-tropic HIV-1. Another approach to circumvent this
roblem is to transfect LuSIV cells with CCR5 and select
table cells using a different selectable marker. Despite
hese limitations, the LuSIV assay system is a useful tool
o study the infectivity of a broad range of HIV and SIV
iral strains.
The use of luciferase as a reporter gene in LTR-based
ssay systems such as ours is not unique. Aguilar-
ordova et al. (1994) have described an LTR-luciferase
assay system in Jurkat cells, although the assay requires
4–5 days before a significant activation of luciferase is
realized. Several other assays utilize LTR-based reporter
constructs for detection of HIV/SIV infection; however,
these systems do not offer the level of sensitivity we
have demonstrated with the LuSIV system (Aguilar-Cor-
dova et al., 1994; Chackerian et al., 1995; Felber and
avlakis, 1988; Gervaix et al., 1997; Kimpton and Emer-
man, 1992).
At present, two of the more common cell-based as-
says used to quantitate HIV/SIV infection are the MAGI
and sMAGI systems. These cell assay systems can de-
tect a single round of infection and determine the infec-
tious titer of a viral stock. However, the cell lines con-
taining the integrated LTR-b-Gal reporter construct used
in both MAGI systems are of the fibroblast lineage and
are not representative of the HIV/SIV host cells in vivo.
These cells require the coexpression of CD4 by trans-
fection and may not provide the best model for viral
infection. In contrast, CEMx174 cells naturally express
CD4 and are a common cell line used to study HIV/SIV
infection. The ability to detect a single round of infection
in MAGI/sMAGI assay systems often requires the addi-
tion of viral inhibitors such as AZT to prevent viral spread
and allow for accumulation of b-gal; therefore, the MAGI/
sMAGI cells are not processed for b-gal activity until 2 to
3 days postinfection. However, we can readily detect
significant luciferase activity 24 h postinfection with the
LuSIV cells that is indicative of a single round of HIV/SIV
infection. When we directly compared the sMAGI and
LuSIV assays, the LuSIV assay was three to eight times
more sensitive using the same virus input and condi-
tions. It is important to note that not only is the LuSIV
assay more sensitive, but it also requires considerably
less time to set up and quantitate the result. In addition,
as a result of the intrinsic properties of each enzyme, the
measurement of b-gal activity can be time consuming,
whereas the time required to measure luciferase activity
is minimal.
We believe the usefulness of the LuSIV cell system
extends beyond its ability to quantitate HIV/SIV infection.
CEMx174 cells are a common cell line used to titer viral
stocks and perform neutralization assays. Both of these
techniques often use cytopathic effect (CPE) or p24/p27production as an indicator of infection. With an adapta-
tion to the LuSIV cells these assays would be easier to
perform without the requirement of visual inspection to
ascertain CPE or the high costs associated with p24/27
assays. Furthermore, the LuSIV cells are not biased
against those strains of HIV/SIV that do not cause CPE
upon infection.
Other applications for the LuSIV cells include high
throughput screening of antiviral agents and replication-
deficient viruses. The LuSIV assay utilizes a 96-well
format that allows for the screening of multiple antivirals
on a single plate in minimal time. Since the LuSIV cells
detect both a single round of replication and virus
spread, they can be used to monitor inhibitors of viral
entry, maturation, specific viral proteins, and other es-
sential steps in the viral life cycle. A strategy used by
several groups in the field of vaccine development is to
generate replication-deficient viruses that are able to
enter the host cell but are unable to establish a produc-
tive infection, usually because of the absence of neces-
sary viral gene(s) or protein(s). The ability of LuSIV cells
to detect small quantities of virus input would make our
assay useful for screening replication-deficient viruses
for safety purposes and/or general infectivity. In addition,
the LuSIV assay system has been used in a recent study
to demonstrate increased infectivity of HIV particles ad-
sorbed to specific adhesion molecules expressed on the
surface of 293 cells (Liao et al., 2000). We believe the
LuSIV assay will allow for the development of new strat-
egies to understand HIV/SIV infection that have currently
been thwarted because of the inability of current tech-
niques to achieve the high sensitivity observed with
LuSIV cells.
MATERIALS AND METHODS
Plasmid constructions
The pLuc reporter construct was made by inserting the
SIVmac239 (2225 3 1149) long terminal repeat (LTR)
pstream of the firefly luciferase reporter gene (de Wet et
l., 1985) into the pCEP4 plasmid (Invitrogen, Carlsbad,
A). The LTR region was amplified by polymerase chain
eaction (PCR) with primers derived from the 59 and 39
egions of the SIVmac239 LTR (2225 3 1149).
The 59 primer (59CTAGGTACCGATGTCGACAGTAT-
GAGGCATATGTTAGATACCC-39) was engineered with
KpnI and SalI restriction sites upstream of the LTR, and
the 39 primer (59-TCTCCATGGCACGAGGGCTTTAAG-
CAAGCGTGG-39) contained an NcoI restriction site
downstream of the LTR. The amplified LTR region was
digested with KpnI and NcoI (Life Technologies, Grand
Island, NY) and subcloned into the pGL3 basic plasmid
(Promega, Madison, WI) directly 59 to the luciferase re-
porter gene. The subclone was digested with SalI (Life
Technologies) to excise the entire expression cassette
containing the SIVmac239 LTR, luciferase reporter gene,
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313LuSIV CELLSand poly(A) signal. This expression cassette was sub-
cloned into pCEP4, which had previously been digested
with SalI to remove the CMV promoter, multicloning site,
and poly(A) signal. The final construct was referred to as
pLuc.
The plasmids containing the SIV Tat gene p11 (Ander-
son and Clements, 1992), the HIV Tat gene RSV-HIV Tat
(NIH AIDS Research and Reference Reagent Program,
Rockville, MD), and the visna virus Tat gene CMV-Tat
(Carruth et al., 1996) have been described.
Cell culture
The B-cell/T-cell hybrid CEMx174 (Salter et al., 1985), a
enerous gift from Dr. James Hoxie (University of Penn-
ylvania), was maintained in RPMI 1640 (Life Technolo-
ies) supplemented with 10% FBS (Atlanta Biologicals,
orcross, GA), 2 mM sodium pyruvate, 10 mM HEPES,
.5 mg/ml gentamicin and 2 mM L-glutamine (cRPMI).
he LuSIV cells were maintained in cRPMI supple-
ented with 300 mg/ml hygromycin B (Boehringer Mann-
heim, Indianapolis, IN) for maintenance of the pLuc plas-
mid.
To generate the LuSIV cells, CEMx174 cells (5 3 105)
were transfected by electroporation with 12 mg pLuc
plasmid DNA. The cells were maintained in cRPMI sup-
plemented with 1 mg/ml hygromycin B to select for sta-
ble transfectants. Once a stable cell line was generated,
the hygromycin concentration was lowered to 300 mg/ml
or maintenance of the pLuc plasmid. These cells were
loned by limiting dilution and the final clone selected
ad the highest signal-to-noise ratio of luciferase activity
pon infection.
The CMMT-CD4-LTR-b-Gal (sMAGI) cells were ob-
ained from Dr. Julie Overbaugh through the AIDS Re-
earch and Reference Reagent Program (Division of
IDS, NIAID, NIH) (Chackerian et al., 1995). The sMAGI
ells were maintained in DMEM supplemented with 10%
BS (Atlanta Biologicals), 2 mM sodium pyruvate, 10 mM
EPES, 0.5 mg/ml gentamicin, and 2 mM L-glutamine
(cDMEM). For maintenance of the CD4 and LTR-b-Gal
plasmids in the sMAGI cells, cDMEM was supplemented
with 700 mg/ml G418 (Boehringer Mannheim) and 140
mg/ml hygromycin B.
Virus stocks
Virus stocks of the molecular clones SIV/17E-Fr (Fla-
herty et al., 1997), SIVmac239 (Daniel et al., 1985; Kestler et
l., 1990; Naidu et al., 1988), and SIVmac251 (Daniel et al.,
985; Naidu et al., 1988) were prepared by transfection of
EMx174 cells with infectious viral DNA. The cells were
ultured in cRPMI until the reverse transcriptase (RT)
ctivity was .80,000 cpm/ml, as determined by a stan-
ard RT assay (Clabough et al., 1991). At the time of
arvest, cell-free supernatants were filtered through a
.45-mM syringe filter (Millipore, Bedford, MA), aliquoted,
E
Lnd stored at 280°C. SIV/17E-Br and SIV/Delta B670 are
virus swarms prepared as previously described (Sharma
et al., 1992). HIV-1 strains (IIIB, RF, MN) were all obtained
from the AIDS Research and Reference Reagent Pro-
gram. The viruses were used to establish chronically
infected PM1 cells as previously described (Orentas and
Hildreth, 1993). Supernatants from infected cells were
used as virus stocks after passage through 0.45-mM
ilters. HIV-1 was quantitated by p24 ELISA (Orentas and
ildreth, 1993).
otransfection of CEMx174 with pLuc
CEMx174 cells (5 3 105) were cotransfected with 6 mg
f pLuc and 6 mg of the plasmids containing SIV Tat, HIV
Tat, visna Tat, or the full -length viral clones HIV/pNL4–3
and SIVmac239 by electroporation using a Bio-Rad Gene
ulser (Bio-Rad, Hercules, CA) set at 200 V and 960 mF.
t various times posttransfection 2 3 105 viable cells
ere analyzed in the luciferase assay.
uSIV infections
Virus was prepared for infection by pelleting 1 ml of
he desired virus input through 100 ml of 20% sucrose/25
M Tris (pH 8.0), 150 mM NaCl, and 2 mM EDTA (TNE)
n a Sorvall 5CRC high-speed centrifuge with an SH-MT
otor at 13,500 rpm for 1 h at 4°C. The supernatant was
oured off and the virus pellet resuspended in phenol
ed-free RPMI 1640 (prfRPMI; Life Technologies) supple-
ented with 2% FBS at the desired inoculum volume. The
uSIV cells were counted by trypan blue exclusion,
ashed one time in prfRPMI, and resuspended in prfR-
MI with 2% FBS to 2.0 3 105 cells/well. The cells were
hen added to the appropriate number of wells in a
6-well flat-bottom plate (Costar, Corning, NY), the virus
noculum was mixed with the cells and the plate was
ncubated at 37°C. For the experiments using the RT
nhibitor, 39-azido-3-deoxythymidine (AZT; Sigma, St.
ouis, MO) LuSIV cells were infected for 6 h, washed two
imes with PBS, and resuspended in 200 ml of prfRPMI
with 2% FBS containing AZT (10 mM). Control wells were
treated with AZT (10 mM) at the time of infection.
Luciferase assay
At the desired time postinfection the LuSIV cells and
medium were transferred from the flat-bottom 96-well
plate to a round-bottom 96-well plate (Costar). The cells
were pelleted at 2500 rpm, the supernatant was re-
moved, and the cell pellet was lysed in 50 ml of 0.5%
riton X-100 in PBS. After 5 min at room temperature, 25
ml of the lysate was analyzed in a Labsystems Fluoro-
skan Ascent FL with injector apparatus. To the lysate,
100 ml of luciferase assay substrate [20 mM Tricine, 1.07
mM (MgCO3)4 z Mg(OH)2 z 5H2O, 2.67 mM MgSO4, 0.1 mMDTA, 270 mM coenzyme A, 470 mM D-luciferin (JBL, San
uis Obispo, CA), 530 mM ATP, and 33.3 mM DTT (Boehr-
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314 ROOS ET AL.inger Mannheim)] (Fortin et al., 1997) were added by
injection. Each well was analyzed individually for 5 s at
he maximum photomultiplier tube (PMT) voltage. The
utput was relative light units (RLU), where an RLU is
rbitrarily determined by the instrument and correlates
ith the photons of light detected in a given sample.
MAGI assays
The day before infection, sMAGI cells were plated into
96-well flat-bottom plate such that the confluency was
0 to 50% for the infection. The next day the media was
emoved and the cells were inoculated with 50 ml of
SIV/17E-Fr (25 ng p27) diluted in cDMEM containing 15
mg/ml DEAE-Dextran (Amersham Pharmacia Biotech,
Piscataway, NJ). After incubation with the virus inoculum
for 2 h at 37°C, an additional 150 ml of cDMEM was
dded to the cells and incubated at 37°C. After 24 h the
ells were fixed and stained for b-Gal activity as previ-
ously described (Chackerian et al., 1995). The extent of
iral infection was determined by visual inspection and
anual quantitation of infectious blue centers. The data
re represented as fold induction of b-Gal activity over
ackground.
irus sensitivity assays
The standard virus input for each assay was 25 ng of
IV p27 or HIV p24 antigen, as determined by enzyme
mmunoassay (Coulter, Miami, FL; Organon Teknika,
urham, NC). LuSIV cells (2 3 105) were infected with
erial fivefold dilutions, starting with 25 ng of SIV p27 or
IV p24 in triplicate. The samples were analyzed in the
uciferase assay at 24 and 48 h postinfection. The data
re represented as fold-induction over background, and
he lowest virus input yielding a fourfold induction was
onsidered the sensitivity limit.
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